Paricalcitol:

IUPAC name:

(1R,3R,7E,17β)-17-[(1R,2E,4S)-5-hydroxy-1,4,5-trimethylhex-2-en-1-yl]-9,10-secoestra-5,7-diene-1,3-diol

CAS No.:131918-61-1

Molecular Formula: C₂₈H₄₄O₃

Molar mass:416.636

Pharmacological action:The drug is19-nor-1,25-(OH)₂-vitamin D₂, is a similar to the calcitriol, vitamin D type of anti parathyroid drugs, for intravenous or oral use. This product inhibits the synthesis and release of parathyroid hormone (PTH) by selective activation of βalso effective in the treatment of equal dose of calcitriol. In the placebo-controlled study, the tendency of induced hypercalcemia and hyperphosphatemia reduce.